The Four Stocks (That Aren’t Pfizer) to Ride the Market’s Vaccine High

An effective vaccine is the only cure to COVID-19, which has seen more than 51 million cases around the world so far.

That’s why news from Pfizer Inc. (NYSE: PFE) regarding a vaccine that’s 90% effective sent the Dow spiking more than 1,500 points, the S&P 500 surging to an all-time high, and Pfizer shares rocketing 15% in a single day.

But here’s a secret I’m only sharing with you…

You see, Pfizer isn’t the biggest and best play here.

There are actually four other stocks – all sector leaders, and each with a hefty upside – that the vaccine revelations will ignite into a big-time run.

These are companies whose businesses and share prices were the hardest-hit by the pandemic – meaning they’ll be the biggest rebound candidates once a vaccine is in place and the world can go back to operating with a sense of normalcy.

For traders like us, this is a setup for the kind of windfall window that comes along just once or twice in a decade…

The COVID-19 Vaccine Will Have These Four Stocks “Rise from the Ashes”

The four stocks we’re looking at today are from sectors that were crushed by the pandemic. Business went down, and as a result, the stock price was hammered.

But that means these are the stocks with the most to gain as the world shows any signs of getting past its COVID-19 limitations.

And the biggest indicator that showed the profit potential on these stocks is how they ran up with Pfizer last Monday.

These were the biggest movers in the S&P 500 on the day of PFE‘s announcement: